Isracann Biosciences Advances Architectural and Security Plans for Israeli Project

Company engages respected contractors with Cannabis sector experience to ensure timely acceptance by government agencies VANCOUVER, British Columbia, Nov. 05, 2019 — Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for...

Isracann Biosciences Launches Phase One Facility Development Program in Israel

Company aims to develop top regional cannabis brands for entry into EU marketplace VANCOUVER, BC, — October 28, 2019 – Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is pleased to provide an operative overview and update regarding facility development activities in Israel. Concurrent to...

Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements

VANCOUVER, British Columbia, Oct. 16, 2019 — Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company has met all conditions to list on the Canadian Securities Exchange. The Company...

Isracann Biosciences Announces Completion of the Acquisition of Isracann Holdings Inc.

VANCOUVER, British Columbia, Oct. 11, 2019) — Isracann Biosciences Inc. (fka Atlas Blockchain Group Inc.) (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce that it has completed its previously announced acquisition (the “Transaction”) of Isracann Holdings Inc. (formerly, Isracann Biosciences Inc.) (“Isracann”). Terms of the Transaction were set out in a...

Atlas Blockchain Announces Conditional Approval of Transaction with Isracann Biosciences Inc.

VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) — Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) wishes to advise that further to its news release dated May 21, 2019, the Canadian Securities Exchange (the “CSE”) has conditionally accepted its proposed transaction (the “Transaction”) with Isracann Biosciences Inc. (“Isracann”), which is...

Israel: A Cannabis Pioneer Then…and Now

By Ash Stringer, July 10th, 2019 — When it comes to cannabis, Israel proves that big things can come in small packages. While recreational marijuana remains illegal in Israel, a country about the size of New Hampshire, the government has been proactive in supporting cannabis research for decades while other countries stagnated in the darkness...

Atlas Blockchain Closes $10.1MM Total Financing for Proposed Acquisition of Israeli Cannabis Operation

–Related News– Company prepares to service growing European demand for quality high grade products VANCOUVER, British Columbia, May 21, 2019 — Atlas Blockchain Group Inc.  (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) is pleased to announce that it has has closed a second tranche of its recently announced private placement, raising total gross...